Utilization of the Essure® micro-insert for the treatment of hydrosalpinx prior to in vitro fertilization

Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication for laparoscopy

“…As far as we know, our study is the largest case-series on this topic. A similar study, but slightly smaller with respect to the number of patients (N ¼ 7), was presented at the annual meeting of the ASRM in 2007 (17). Both caseseries show good pregnancy rates with IVF-ET following Essure placement, which are in line with those found after laparoscopic salpingectomy (10).…”

“…In the last 3 years four reports (15)(16)(17)(18) on the use of Essure devices for the treatment of hydrosalpinx before IVF have been published. As far as we know, our study is the largest case-series on this topic.…”

“…A significant concern in using Essure devices for the treatment of hydrosalpinx in women wishing to conceive is the trailing of Essure coils into the uterine cavity and its possible effects on implantation as well as on pregnancy. Therefore, we decided, in line with other investigators (16)(17)(18), to limit the number of coils remaining in the cavity to three. Our experience is that this is usually feasible.…”

Proximal occlusion of hydrosalpinges by Essure® before assisted reproduction techniques: a French survey

“…Nonetheless their efficacy remains unproved, due to the small number of studies, often retrospective and small. Placement of Essure 1 microinserts before ART is currently the alternative that has shown best results, since seven studies have been reported, all concluding favourably [11][12][13][14][15][16][17]. Transvaginal aspiration of the hydrosalpinx on the day of the oocyte retrieval remains a controversial option because the fluid accumulation is known to reconstitute within several hours [23].…”

“…The surgical risk during laparoscopy, especially for women with major pelvic adhesions, has led some surgeons to use Essure 1 for hysteroscopic tubal occlusion, an off-label use different from its primary purpose of tubal sterilisation. Currently, seven small studies [11][12][13][14], including prospective randomised trials [15,16] and a controlled study [17], have produced fairly positive results. We sought to assess the feasibility and short-and intermediateterm results of this practice in a nationwide enquiry.…”